Not yet recruitingPhase 3NCT07468526

An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria

Studying Malaria

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Menzies School of Health Research
Principal Investigator: Kamala Thriemer, Professor
Menzies School of Health Research
Intervention: High dose ultra short Primaquine(drug)
Enrollment: 1019 enrolled
Eligibility: 5 years · All sexes
Timeline: 2026 – 2028

Study locations (5)

Arba Minch University, Arba Minch, Arba Minch, Ethiopia
Jimma University, Jimma, Jimma, Ethiopia
Universitas Sumatera, Bandar Lampung, Lampung, Indonesia
Aga Khan University, Karachi, Karachi, Thatta, Pakistan
Papua New Guinea Institute of Medical Research, Port Moresby, Magang, Papua New Guinea

Collaborators

Curtin University · University of Melbourne · Papua New Guinea Institute of Medical Research · Arba Minch University · Jimma University · Universitas Sumatera Utara · Aga Khan University · PathWest Laboratory Medicine WA

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07468526 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials